Objective: The most serious side effect of warfarin, an oral anticoagulant widely prescribed by many different disciplines, is bleeding. In this study, the factors affecting the bleeding complications resulting from the use of warfarin were investigated.Material and Methods: In this study, 111 patients using warfarin and admitted to the emergency department with bleeding complaints were evaluated. All patients were divided into two groups as Group I (international normalized ratio >3.5) and Group II (international normalized ratio ≤3.5) according to the "international normalized ratio" value at the time of admission. The groups were compared in terms of demographic characteristics, admission complaint, indications for warfarin use, concomitant diseases, other drugs used, duration of warfarin use, international normalized ratio value, bleeding localization, treatment and interventions.Results: Of the 115 patients, 85 were in Group I and 26 were in Group II. Fifty-six (50.5%) of the patients were women. In our study, the most common reason for warfarin use was heart valve replacement (46.8%). The most common complaint was bloody stool (41.5%). Of the patients, 79 of had at least one concomitant disease. The most common comorbid disease of our patients was hypertension (n=50, 45%). Seventy-six patients were found to have major bleeding and major bleeding was higher in Group I.Conclusion: It was determined that major bleeding and need for hospitalization were higher in patients with an international normalized ratio value >3.5, and the follow-up period in the emergency department was longer. Although the international normalized ratio value is an important factor for warfarin-induced bleeding, the international normalized ratio value is not the only cause of bleeding and additional factors may be responsible for bleeding.
Aim: This study aimed to evaluate the relationship between prognosis and model for end-stage liver disease (MELD) score, albumin, bilirubin, and international normalized ratio (INR) levels in patients diagnosed with hepatic encephalopathy (HE) based on Child-Pugh staging. Material and Methods: This prospective observational study included a total of 49 patients diagnosed with cirrhosis of the liver who presented to the emergency department due to HE. Clinical findings and laboratory values of the patients were prospectively recorded. Each patient's Child-Pugh score, MELD score, INR, albumin, total and direct bilirubin levels were determined and compared according to the Child-Pugh stage. Results: Of the 49 patients included in the study, 32 (65.3%) were male and 17 (34.7%) were female, and the median age was 57 (range, 46-85) years. Of the patients, 28 (57.1%) were in Child-Pugh stage B, and 21 (42.9%) were in Child-Pugh stage C. The most commonly observed encephalopathy symptoms were ataxia (93.9%, n=46) and amnesia (81.6%, n=40). MELD score, INR, and bilirubin levels were found significantly higher in the Child-Pugh C group compared to the Child-Pugh B group (p
18 August 2021 in Journal of Emergency Medicine Case Reports
A snakebite is an injury caused by a bite from a snake, often resulting in puncture wounds inflicted by animal’s fangs and sometimes resulting in envenomation. Venom may cause a complex condition that can be local damage, neuromuscular dysfunction, or systemic vascular damage leading to hemolysis. The main cause of mortality and morbidity in snake bites is neurotoxicity, and the main cause of neurotoxicity is sudden neuromuscular paralysis. Synthesis, packaging, transport, and release of the neurotransmitter acetylcholine in the presynaptic field, blockade of postsynaptic nicotinic acetylcholine receptors, acetylcholine esterase inhibition, muscarinic effects of some snake toxins, and inhibition of voltage-gated calcium gates, changes in the neuromuscular junction after snakebite can explain neuromuscular paralysis secondary to the snake bite. We present a case, with bilateral diplopia and ptosis after snakebite, that was recovered after the use of anticholinesterase therapy and antivenom.